NEW YORK – Genome British Columbia announced Monday C$10 million (US$7.5 million) to fund studies of the effectiveness of genomics in healthcare.
Researchers at the University of British Columbia, led by Anna Lehman of the Department of Medical Genetics, received C$8.1 million to evaluate the feasibility of integrating whole-genome sequencing into the standard of care for rare disease patients.